4//SEC Filing
Harsanyi Zsolt 4
Accession 0001209191-22-033930
CIK 0001671584other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 3:10 PM ET
Size
10.5 KB
Accession
0001209191-22-033930
Insider Transaction Report
Form 4
Harsanyi Zsolt
Director
Transactions
- Exercise/Conversion
Common Stock
2022-06-01+298→ 4,607 total - Exercise/Conversion
Restricted Stock Unit
2022-06-01−298→ 595 total→ Common Stock (298 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]Shares beneficially owned by the reporting person were adjusted to include the following shares of the Issuer's common stock: (i) 210 shares that were inadvertently omitted from the Form 4 filed on August 5, 2016; and (ii) 527 shares that were originally disclosed in the Form 4 filed on August 5, 2016, but due to a mathematical error, were not included in the aggregate number of shares beneficially owned in the Form 4 filed on June 7, 2019. In each of subsections (i) and (ii) above, the number of shares were adjusted to reflect a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020.
- [F3]On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001380184
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 3:10 PM ET
- Size
- 10.5 KB